B. Godeau

L. Brochard, C. Brun-Buisson, Y. Lévy, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients

C. Bénéteau, E. Deconinck, L. Garçon, 2019, Haematologica.

Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases.

J. Piette, F. Roudot-thoraval, P. Bierling, 2002, The Journal of rheumatology.

Prolonged remission of SLE-associated polyradiculoneuropathy after a single course of intravenous immunoglobulin.

C. Brun-Buisson, P. Bierling, A. Schaeffer, 1996, Scandinavian journal of rheumatology.

CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments

R. D. Du Pasquier, R. Bernard-Valnet, G. Martin-Blondel, 2021, Neurology: Neuroimmunology & Neuroinflammation.

Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?

O. Lambotte, V. Ribrag, M. Ebbo, 2019, European journal of cancer.

Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.

E. Neufeld, P. Bierling, J. Bussel, 2012, Blood.

Procalcitonin to Reduce Antibiotic Exposure during Acute Chest Syndrome in Adult Patients with Sickle-Cell Disease

C. Brun-Buisson, B. Godeau, M. Khellaf, 2020, Journal of clinical medicine.

Characteristics, risk factors and management of venous thromboembolism in immune thrombocytopenia: a retrospective multicentre study

B. Bonnotte, M. Michel, B. Godeau, 2019, Internal medicine journal.

The hematologic manifestations of the antiphospholipid syndrome.

M. Khamashta, A. Taher, B. Godeau, 2008, Blood reviews.

Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: value for diagnostic assessment of fat embolism.

A. Rahmouni, C. Brun-Buisson, F. Lebargy, 1996, American journal of respiratory and critical care medicine.

Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort

M. Lapeyre-Mestre, G. Moulis, L. Sailler, 2017, American journal of hematology.

Second-line and beyond: treatment options for primary persistent and chronic immune thrombocytopenia

B. Godeau, S. Deshayes, 2020, Platelets.

Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios : A Randomize

A. Rahmouni, L. Brochard, N. Abidi, 2011 .

Rituximab and immune thrombocytopenia in adults: The state of knowledge 20 years later

B. Godeau, M. Mahévas, S. Deshayes, 2020, La Revue de medecine interne.

Updated international consensus report on the investigation and management of primary immune thrombocytopenia.

J. Bussel, B. Chong, Y. Tomiyama, 2019, Blood advances.

Is B-cell depletion still a good strategy for treating immune thrombocytopenia?

R. Stasi, B. Godeau, 2014, Presse medicale.

Efficacy and safety of rituximab in common variable immunodeficiency‐associated immune cytopenias: a retrospective multicentre study on 33 patients

C. Cunningham-Rundles, B. Bonnotte, R. Jaussaud, 2011, British journal of haematology.

Patterns of mortality in sickle cell disease in adults in France and England.

F. Roudot-thoraval, D. Bachir, F. Galactéros, 2002, The hematology journal : the official journal of the European Haematology Association.

Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: Retrospective analysis of 27 cases

B. Bonnotte, J. Viallard, A. Dechartres, 2009, American journal of hematology.

Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant

A. Meola, F. Rey, J. Pawlotsky, 2022, Immunity.

Immune escape of SARS-CoV-2 Omicron variant from mRNA vaccination-elicited RBD-specific memory B cells

A. Meola, F. Rey, J. Pawlotsky, 2021, bioRxiv.

Early intermittent noninvasive ventilation for acute chest syndrome in adults with sickle cell disease: a pilot study

L. Brochard, D. Bachir, F. Galactéros, 2010, Intensive Care Medicine.

Is there still a place for "old therapies" in the management of immune thrombocytopenia?

B. Bonnotte, B. Godeau, S. Audia, 2016, La Revue de medecine interne.

Induced sputum versus bronchoalveolar lavage during acute chest syndrome in sickle cell disease.

L. Brochard, B. Housset, D. Bachir, 2003, American journal of respiratory and critical care medicine.

CCR5 Blockade in In ﬂ ammatory PML and PML-IRIS Associated With Chronic In ﬂ ammatory Diseases ’ Treatments

R. D. Pasquier, R. Bernard-Valnet, G. Martin-Blondel, 2022 .

E. Andrès, L. Chiche, J. Berthelot, 2012, Medicine.

Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease.

E. Audureau, P. Grimbert, P. Lang, 2016, Journal of the American Society of Nephrology : JASN.

Thrombopoietin receptor agonists: ten years later

J. Bussel, F. Rodeghiero, B. Godeau, 2019, Haematologica.

CD36 deficiency is frequent and can cause platelet immunization in Africans

N. Debili, P. Bierling, D. Bachir, 1999, Transfusion.

Posttransfusion purpura‐like syndrome associated with CD36 (Naka) isoimmunization

W. Vainchenker, N. Debili, J. Rouby, 1995, Transfusion.

Management of immune thrombocytopenia in adults: a population‐based analysis of the French hospital discharge database from 2009 to 2012

J. Viallard, M. Michel, B. Godeau, 2015, British journal of haematology.

Autoimmune Thrombocytopenic Purpura and Common Variable Immunodeficiency: Analysis of 21 Cases and Review of the Literature

É. Oksenhendler, P. Bierling, Y. Lévy, 2004, Medicine.

Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1 g/kg b.w.

P. Bierling, A. Schaeffer, B. Godeau, 1999, British journal of haematology.

Thymic Epithelial Tumor‐Associated Cytopenia: A 10‐Year Observational Study in France

N. Girard, J. Viallard, B. Besse, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia

P. Fenaux, L. Adès, K. Laribi, 2021, Haematologica.

Immune thrombocytopenia in chronic myelomonocytic leukemia

J. Hadjadj, M. Michel, B. Godeau, 2014, European journal of haematology.

intravenous cyclophosphamide . erythematosus : beneficial effect of Bronchiolitis obliterans in systemic lupus

C. Menkes, C. Cormier, B. Godeau, 2022 .

Switching thrombopoietin receptor agonist treatments in patients with primary immune thrombocytopenia

J. González-Porras, B. Godeau, M. Carpenedo, 2019, Therapeutic advances in hematology.

Splenectomy for Primary Immune Thrombocytopenia revisited in the era of Thrombopoietin Receptor Agonists: new insights for an old treatment.

B. Bonnotte, P. Jeandel, N. Costedoat-Chalumeau, 2021, American journal of hematology.

Traitement du purpura thrombopénique auto-immun de l'adulte

B. Godeau, P. Bierling, 1996 .

[Treatment of autoimmune thrombopenic purpura in adults].

P. Bierling, B. Godeau, 1996, La Revue de medecine interne.

Treatment of primary autoimmune thrombocytopenia (AITP) [1]

Y. Tomiyama, I. Pabinger, H. Reesink, 2012, Vox sanguinis.

primary immune thrombocytopenia International consensus report on the investigation and management of

V. Blanchette, D. Cines, B. Chong, 2010 .

Long‐term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP‐ritux

G. Salles, J. Viallard, L. Galicier, 2019, American journal of hematology.

Vincristine efficacy and safety in treating immune thrombocytopenia: a retrospective study of 35 patients

P. Bierling, P. Fenaux, V. Prendki, 2016, European journal of haematology.

Preferential splenic CD8(+) T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia.

B. Bonnotte, C. Ferrand, P. Saas, 2013, Blood.

Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia

F. Roudot-thoraval, P. Bierling, B. Bonnotte, 2013, American journal of hematology.

[Immune thrombocytopenias: pathophysiology and treatment].

B. Godeau, 2013, Bulletin de l'Academie nationale de medecine.

How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment.

J. Bussel, D. Cines, B. Godeau, 2012, Blood.

or a medical therapy as a second-line treatment How I treat immune thrombocytopenia: the choice between splenectomy

J. Bussel, D. Cines, B. Godeau, 2012 .

Costs of managing severe immune thrombocytopenia in adults: a retrospective analysis

P. Bierling, L. Eckert, R. Launois, 2011, Annals of Hematology.

Treatment of chronic immune thrombocytopenic purpura in adults

M. Michel, B. Godeau, 2010, Annals of Hematology.

[Immune thrombocytopenic purpura: pathophysiology and treatment].

B. Godeau, 2009, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[Treatment of idiopathic thrombocytopenic purpura in adults].

P. Bierling, B. Godeau, 2008, Presse medicale.

Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count.

P. Bierling, A. Waage, A. Sundan, 2005, Haematologica.

Long‐term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials

D. Cines, J. Viallard, A. Giagounidis, 2013, European journal of haematology.

Diagnosis of autoimmune lymphoproliferative syndrome caused by FAS deficiency in adults

F. Rieux-Laucat, A. Fischer, C. Picard, 2013, Haematologica.

P. Bierling, B. Godeau, 1997 .

Dapsone for autoimmune thrombocytopenic purpura

É. Oksenhendler, P. Bierling, B. Godeau, 1993, American journal of hematology.

Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin.

P. Bierling, B. Godeau, J. Farcet, 1993, Blood.

Intravenous immunoglobulin for autoimmune thrombocytopenic purpura.

P. Bierling, B. Godeau, 2005, Human immunology.

Intravenous immunoglobulin and autoimmune thrombocytopenic purpura: 22 years on

P. Bierling, B. Godeau, 2004, Vox sanguinis.

Dapsone for chronic autoimmune thrombocytopenic purpura: a report of 66 cases

É. Oksenhendler, F. Roudot-thoraval, P. Bierling, 1997, British journal of haematology.

Delayed hemolytic transfusion reaction in adult sickle‐cell disease: presentations, outcomes, and treatments of 99 referral center episodes

C. Rieux, F. Pirenne, D. Bachir, 2016, American journal of hematology.

Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase IIb trial

J. Weill, C. Reynaud, F. Batteux, 2020, Haematologica.

Characteristics and outcome of immune thrombocytopenia in elderly: Results from a single center case‐controlled study

P. Bierling, M. Michel, B. Godeau, 2011, American journal of hematology.

First evidence of subclinical renal tubular injury during sickle-cell crisis

Y. Lévy, P. Grimbert, P. Lang, 2014, Orphanet Journal of Rare Diseases.

Bortezomib and dexamethasone, an original approach for treating multi‐refractory warm autoimmune haemolytic anaemia

É. Oksenhendler, L. Galicier, M. Michel, 2019, British Journal of Haematology.

A novel approach to the evaluation of bleeding-related episodes in patients with chronic immune thrombocytopenia

B. Godeau, D. Henry, M. Gleeson, 2012, Current medical research and opinion.

Acute Arterial Obliteration: A New Feature of the POEMS Syndrome?

F. Authier, L. Bélec, R. Gherardi, 1996, Medicine.

FUSIDIC ACID INDUCED ACUTE IMMUNOLOGIC THROMBOCYTOPENIA

P. Kalfon, P. Bierling, P. Fromont, 1996, British journal of haematology.

Platelet alloimmunization after multiple transfusions: a prospective study of 50 patients

P. Bierling, P. Fromont, B. Godeau, 1992, British journal of haematology.

Brb, a Platelet Alloantigen Involved in Neonatal Alloimmune Thrombocytopenia

P. Bierling, P. Fromont, B. Godeau, 1991, Vox sanguinis.

Emergence of long-lived autoreactive plasma cells in the spleen of primary warm auto-immune hemolytic anemia patients treated with rituximab.

K. Tarte, J. Weill, C. Reynaud, 2015, Journal of autoimmunity.

Haematological determinants of cardiac involvement in adults with sickle cell disease.

J. Dubois-Randé, L. Hittinger, F. Galactéros, 2016, European heart journal.

Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination

J. Casanova, M. Zins, S. Tangye, 2022, The Journal of experimental medicine.

Short and longterm outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients.

S. Chevret, C. Chastang, J. Carlet, 1997, The Journal of rheumatology.

Neutropenia in Felty's syndrome successfully treated with hydroxychloroquine.

M. Michel, B. Godeau, M. Mahévas, 2007, Haematologica.

Autologous111Indium‐oxinate‐labelled platelet sequestration study in patients with immune thrombocytopenia treated by thrombopoietin receptor‐agonists

L. Vercellino, P. Bierling, J. Tamburini, 2019, British journal of haematology.

Autologous 111 Indium-Oxinate-Labelled Platelet Sequestration Study in Patients with Immune Thrombocytopenia Treated By Thrombopoietic Receptor-Agonists

P. Bierling, J. Tamburini, L. Galicier, 2016 .

Glomerular Lesions in Patients With Sickle Cell Disease

O. Lambotte, P. Lang, P. Niaudet, 2010, Medicine.

The response to high‐dose intravenous immunoglobulin or steroids is not predictive of outcome after splenectomy in adults with autoimmune thrombocytopenic purpura

P. Bierling, O. Tournilhac, A. Schaeffer, 1999, British journal of haematology.

Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 Patients

J. Piette, L. Mouthon, N. Costedoat-Chalumeau, 2022, JAMA Dermatology.

Acute swelling of the limbs: magnetic resonance pictorial review of fascial and muscle signal changes.

A. Rahmouni, J. Roujeau, O. Chosidow, 1999, European journal of radiology.

Monoclonal Anti-CD20 (B-Cell) Antibody and Autoimmune Diseases

B. Godeau, 2018 .

Long term evolution of adult onset Still ' s disease seen in an infectious diseases

C. Leport, B. Godeau, C. Perronne, 2022 .

Kinetic Profiles and Management of Hepatitis B Virus Reactivation in Patients With Immune‐Mediated Inflammatory Diseases

D. Thabut, F. Berenbaum, S. Pol, 2013, Arthritis care & research.

[Rapidly progressive glomerulonephritis in macroscopic periarteritis nodosa. 7 cases].

G. Lambrey, B. Godeau, L. Guillevin, 1993, Annales de medecine interne.

[Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study].

I. Durieu, M. Pérault-Pochat, A. Jonville-Béra, 2017, La Revue de medecine interne.

A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia

F. Roudot-thoraval, P. Bierling, J. Viallard, 2013, Haematologica.

A randomized and double‐blind controlled trial evaluating the safety and efficacy of rituximab for warm auto‐immune hemolytic anemia in adults (the RAIHA study)

F. Roudot-thoraval, L. Galicier, L. Frenzel, 2017, American journal of hematology.

Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis.

J. Piette, F. Roudot-thoraval, E. Hachulla, 1995, Annals of the rheumatic diseases.

IgA-mediated human autoimmune hemolytic anemia as a result of hemagglutination in the spleen, but independent of complement activation and FcαRI.

C. Copie-Bergman, P. Bierling, G. Bodivit, 2010, Blood.

International consensus report on the investigation and management of primary immune thrombocytopenia.

Drew Provan, Robert McMillan, Shirley Watson, 2010, Blood.

Antibodies in the Therapy of Autoimmune Thrombocytopenia

P. Bierling, B. Godeau, 1997, BioDrugs.

Clinical characteristics, management and outcome of COVID‐19‐associated immune thrombocytopenia: a French multicentre series

E. Andrès, L. Galicier, C. Guerveno, 2020, British journal of haematology.

Severe, non specific symptoms in non-typhoidal Salmonella infections in adult patients with sickle cell disease: a retrospective multicentre study

J. Mainardi, F. Galactéros, M. Michel, 2018, Infectious diseases.

Disseminated Aseptic Abscesses Associated with Crohn's Disease (A New Entity?)

J. Piette, D. Vital-Durand, Jeannot Schmidt, 1998, Digestive Diseases and Sciences.

Is Still's disease associated with parvovirus B19 infection?

A. Schaeffer, B. Godeau, F. Morinet, 1995, The Lancet.

Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases.

J. Piette, J. Rossert, B. Godeau, 1994, The Journal of rheumatology.

Thrombocytopenia following Pfizer and Moderna SARS‐CoV‐2 vaccination

Eun-Ju Lee, J. Bussel, C. Kessler, 2021, American journal of hematology.

Understanding Immune Thrombocytopenia: Looking Out of the Box

F. Cavalli, B. Godeau, T. Kühne, 2021, Frontiers in Medicine.

Causes of Death in Sickle Cell Disease Adult Patients: Old and New Trends

F. Galactéros, B. Godeau, P. Bartolucci, 2014 .

A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults.

F. Roudot-thoraval, D. Bachir, F. Galactéros, 2009, Blood.

mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants

A. Meola, F. Rey, J. Pawlotsky, 2021, Immunity.

Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B‐cell lymphoma

O. Tournilhac, Eléonore Kaphan, M. Michel, 2022, European journal of haematology.

Risk factors associated with intracranial hemorrhage in adults with immune thrombocytopenia: A study of 27 cases

M. Boubaya, J. Viallard, L. Galicier, 2016, American journal of hematology.

Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France.

M. Lapeyre-Mestre, J. Montastruc, G. Moulis, 2014, Blood.

Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients.

G. Salles, F. Roudot-thoraval, P. Bierling, 2014, Blood.

Rituximab-resistant splenic memory B cells and newly engaged naive B cells fuel relapses in patients with immune thrombocytopenia

J. Weill, C. Reynaud, V. Meignin, 2021, Science Translational Medicine.

Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: A systematic review and meta-analysis.

M. Lapeyre-Mestre, F. Montastruc, E. Svenungsson, 2016, Autoimmunity reviews.

Primary immune thrombocytopenia in very elderly patients: particularities in presentation and management: results from the prospective CARMEN‐France Registry

G. Moulis, O. Beyne-Rauzy, M. Michel, 2021, British journal of haematology.

Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥65 years with immune thrombocytopenia

Y. Tomiyama, L. Aledort, J. Wasser, 2015, Annals of Hematology.

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Julie M. Woessner, P. Hennequin, Cécile Paris, 2021, The Lancet Rheumatology.

The temporary use of thrombopoietin‐receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study

F. Roudot-thoraval, P. Bierling, M. Ebbo, 2014, British journal of haematology.

How we manage immune thrombocytopenia in the elderly

M. Michel, B. Godeau, M. Mahévas, 2016, British journal of haematology.

Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group.

J. Bussel, V. Blanchette, D. Cines, 2013, Blood.

A case of acute eosinophilic pneumonia with hypersensitivity to "red spider" allergens.

L. Brochard, F. Lemaire, F. Lebargy, 1995, The Journal of allergy and clinical immunology.

Psoas abscess: An unusual manifestation of Q fever.

M. Michel, B. Godeau, L. Deforges, 2007, European journal of internal medicine.

[Chronic bone infections after surgery. Treatment with the new quinolones].

C. Leport, B. Godeau, D. Salmon, 1989, Presse medicale.

Cerebral venous thrombosis in a patient with antiphospholipid syndrome treated with thalidomide.

M. Michel, A. Schaeffer, B. Godeau, 2004, Lupus.

[Thrombocytopenia and pregnancy].

P. Bierling, M. Michel, B. Godeau, 2012, La Revue de medecine interne.

[Characteristics of autoimmune hemolytic anemia in adults: retrospective analysis of 83 cases].

O. Hermine, M. Michel, A. Schaeffer, 2002, La Revue de medecine interne.

Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study

J. Viallard, A. Orejudos, A. Newland, 2016, British journal of haematology.

Rabies encephalitis in a patient with AIDS: a clinicopathological study

H. Adle-Biassette, F. Chrétien, M. Baudrimont, 1996, Acta Neuropathologica.

Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study.

T. Tvedt, J. Bussel, M. Ebbo, 2020, Blood.

[Immune thrombocytopenia and pregnancy: State of knowledge and unanswered questions].

L. Mandelbrot, O. Pourrat, B. Godeau, 2015, La Revue de medecine interne.

Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim

J. Wasser, B. Godeau, R. Lyons, 2015, International Journal of Hematology.

[IgA-mediated auto-immune haemolytic anaemia revealing a hepatitis C virus infection].

F. Noizat‐Pirenne, M. Michel, B. Godeau, 2008, La Revue de medecine interne.

Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome

J. Piette, P. Bierling, P. Fromont, 1997, British journal of haematology.

Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data

P. Ravaud, N. Roche, J. Pawlotsky, 2020, BMJ.

Hydroxychloroquine is a good second‐line treatment for adults with immune thrombocytopenia and positive antinuclear antibodies

F. Roudot-thoraval, P. Bierling, M. Michel, 2014, American journal of hematology.

Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia.

É. Oksenhendler, D. Boutboul, M. Cheminant, 2021, Haematologica.

Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry.

E. Vignon, P. Ravaud, X. Mariette, 2010, Arthritis and rheumatism.

[Mycobacterium kansasii extensive subcutaneous infection in dermatomyositis].

B. Godeau, H. Schill, H. Mayaudon, 1990, Annales de medecine interne.

Bloodstream Infection in Adults With Sickle Cell Disease: Association With Venous Catheters, Staphylococcus aureus, and Bone-Joint Infections

F. Roudot-thoraval, C. Brun-Buisson, J. Zahar, 2006, Medicine.

Sickle‐cell disease stroke throughout life: A retrospective study in an adult referral center

D. Calvet, H. Hosseini, D. Bachir, 2014, American journal of hematology.

NK cell compartment in the peripheral blood and spleen in adult patients with primary immune thrombocytopenia.

J. Viallard, F. Vély, J. Harlé, 2017, Clinical immunology.

Older Adults and Immune Thrombocytopenia: Considerations for the Clinician

M. Michel, B. Godeau, M. Mahévas, 2023, Clinical interventions in aging.

Multiple thrombosis in a patient with Gardos channelopathy and a new KCNN4 mutation

G. Bouyer, L. Garçon, L. Kiger, 2021, American journal of hematology.

Romiplostim in adults with newly diagnosed or persistent immune thrombocytopenia

F. Rodeghiero, B. Godeau, D. Kuter, 2020, Expert review of hematology.

An Interim Analysis Of a Phase 2, Single-Arm Study Of Platelet Responses and Remission Rates In Patients With Immune Thrombocytopenia (ITP) Receiving Romiplostim

J. Viallard, A. Orejudos, A. Newland, 2013 .

Evaluation of Bleeding-Related Episodes in Patients with Chronic Immune Thrombocytopenia (ITP) Treated with Romiplostim in Two Phase 3 Placebo-Controlled Clinical Trials.

B. Godeau, D. Henry, M. Gleeson, 2009 .

Relapse of posttransfusion purpura after transfusion with frozen‐thawed red cells

P. Bierling, P. Fromont, B. Godeau, 1991, Transfusion.

Immune thrombocytopenic purpura: major progress in knowledge of the pathophysiology and the therapeutic strategy, but still a lot of issues.

B. Godeau, 2014, Presse medicale.

Characteristics, management and outcome of acquired amegakaryocytic thrombocytopenia

M. Ebbo, G. Moulis, M. Michel, 2021, British journal of haematology.

Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients

F. Roudot-thoraval, Y. Lévy, F. Galactéros, 2016, EBioMedicine.

The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells.

Jacques-Olivier Pers, Olivier Hermine, Antonio Cosma, 2008, Blood.

Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine

C. Morélot-Panzini, Z. Amoura, D. Sène, 2020, Annals of the Rheumatic Diseases.

Hypersensitivity to azathioprine mimicking gastroenteritis. Absence of recurrence with 6-mercaptopurine.

A. Schaeffer, B. Godeau, A. Astier, 1995, Gastroenterologie clinique et biologique.

Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease

J. Lelièvre, R. Djoudi, F. Pirenne, 2017, American journal of hematology.

[Retroperitoneal fibrosis in adults: Main characteristics and relevance of the diagnostic procedures based on a retrospective multicenter study on 77 cases].

D. Vordos, M. Michel, B. Godeau, 2016, La Revue de medecine interne.

Vaccination in adults with auto-immune disease and/or drug related immune deficiency: results of the GEVACCIM Delphi survey.

J. Pouchot, X. Mariette, E. Hachulla, 2009, Vaccine.

Vasculitis restricted to the lower limbs: a clinical and histopathological study

J. Brisseau, M. Hamidou, M. Michel, 2006, Annals of the rheumatic diseases.

Rituximab failure in a patient with monoclonal gammopathy of undetermined significance (MGUS)- associated acquired von Willebrand syndrome

B. Godeau, M. Khellaf, P. Bartolucci, 2008, Thrombosis and Haemostasis.

Update in Neurocritical Care: a summary of the 2018 Paris international conference of the French Society of Intensive Care

L. Puybasset, N. Weiss, S. Jaber, 2019, Annals of Intensive Care.

Immunomodulation and immune thrombocytopenia: some unmet needs, questions, and outlook.

B. Godeau, 2016, Seminars in hematology.

Treatment of neurosarcoidosis

R. Borie, Z. Amoura, D. Valeyre, 2016, Neurology.

Clinical phenotypes of extra-pulmonary sarcoidosis. The EpiSarc study

I. Annesi-Maesano, R. Borie, Z. Amoura, 2018, Sarcoidosis and other granulomatous ILD/DPLD.

Memory B cells control SARS-CoV-2 variants upon mRNA vaccination of naive and COVID-19 recovered individuals

A. Meola, F. Rey, J. Pawlotsky, 2021, bioRxiv.

Safety of anti‐SARS‐CoV‐2 vaccination for patients with immune thrombocytopenia

M. Ebbo, G. Moulis, M. Michel, 2021, British journal of haematology.

Utilization of intravenous or subcutaneous immunoglobulins in secondary immune deficiency (ULTIMATE): A retrospective multicenter study.

I. Durand-zaleski, A. Caumont-Prim, L. Mouthon, 2020, Clinical immunology.

Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T‐cell lymphoma

P. Gaulard, O. Casasnovas, L. de Leval, 2019, European journal of haematology.

Les anticorps antiphospholipides, signification et traitement

J. Piette, B. Godeau, 2004 .

High‐dose methylprednisolone is an alternative treatment for adults with autoimmune thrombocytopenic purpura refractory to intravenous immunoglobulins and oral corticosteroids

P. Bierling, A. Schaeffer, B. Godeau, 1995, American journal of hematology.

TREATMENT OF CHRONIC AUTOIMMUNE THROMBOCYTOPENIC PURPURA WITH ASCORBATE

P. Bierling, B. Godeau, 1990, British journal of haematology.

[The significance and treatment of antiphospholipid antibodies].

J. Piette, B. Godeau, 2004, Presse medicale.

Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort

R. Salomon, E. Daugas, A. Jamin, 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry.

M. Dougados, G. Baron, P. Ravaud, 2010, Arthritis & Rheumatism.

Protein‐Losing Enteropathy in Gastrointestinal Sarcoidosis Associated with Malignant Lymphoma

P. Gaulard, B. Godeau, J. Farcet, 1992, Journal of clinical gastroenterology.

Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.

E. Messas, Z. Amoura, J. Sibilia, 2015, Circulation.

[Pneumocystis pneumonia among patients with systemic diseases].

B. Godeau, M. Khellaf, 2009, Presse medicale.

Long term evolution of adult onset Still's disease seen in an infectious diseases department.

C. Leport, B. Godeau, M. Kahn, 1991, Annals of the rheumatic diseases.

Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study

C. Cazalets, P. Dieudé, X. Mariette, 2022, The Lancet Rheumatology.

Omicron BA.1 breakthrough infection drives long-term remodeling of the memory B cell repertoire in vaccinated individuals

A. Meola, F. Rey, J. Pawlotsky, 2023, bioRxiv.

Lung imaging during acute chest syndrome in sickle cell disease: computed tomography patterns and diagnostic accuracy of bedside chest radiograph

A. Rahmouni, J. Deux, C. Brun-Buisson, 2013, Thorax.

Prevalence and Clinical Significance of Elevated Antiphospholipid Antibodies in Adults with Immune Thrombocytopenic Purpura.

P. Bierling, M. Michel, B. Godeau, 2006 .

Dapsone in Thrombocytopenia of the Antiphospholipid Antibody Syndrome

B. Wechsler, B. Godeau, P. Lesprit, 1995, Annals of Internal Medicine.

[Treatment of major sickle cell syndromes. The point of view of the internist].

B. Godeau, 2001, Bulletin de la Societe de pathologie exotique.

De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring

G. Moulis, M. Michel, B. Godeau, 2022, Blood.

Screening for Autoimmune Markers Is Unnecessary during Follow-up of Adults with Autoimmune Thrombocytopenic Purpura and no Autoimmune Markers at Onset

P. Bierling, B. Godeau, C. André, 2000, Thrombosis and Haemostasis.

Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome

L. Abenhaim, B. Bonnotte, N. Costedoat-Chalumeau, 2016, Haematologica.

[Persistence of accessory spleen after splenectomy for auto-immune thrombocytopenic purpura: apropos of 2 cases].

P. Bierling, B. Godeau, 1991, La Revue de medecine interne.

Outcome of patients with systemic rheumatic disease admitted to medical intensive care units.

C. Chastang, J. Dhainaut, F. Brunet, 1992, Annals of the rheumatic diseases.

Systematic detection of portal or splenic vein thrombosis after splenectomy for immune cytopenia

F. Brunetti, P. Bierling, M. Michel, 2018, American journal of hematology.

Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.

A. Rahmouni, J. Deux, P. Brugières, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Bronchiolitis obliterans in systemic lupus erythematosus: beneficial effect of intravenous cyclophosphamide.

C. Menkes, C. Cormier, B. Godeau, 1991, Annals of the rheumatic diseases.

Seasonal variations of incident primary immune thrombocytopenia in adults: An ecological study.

P. Bierling, G. Moulis, M. Michel, 2017, European journal of internal medicine.

No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial

P. Ravaud, N. Roche, L. Mouthon, 2020, medRxiv.

Adolescents and Young Adults with Immune Thrombocytopenia (ITP): A Project of the Carmen-France and Parc-ITP Registry

G. Leverger, T. Leblanc, S. Holzhauer, 2021, Blood.

Outcome of Immune Thrombocytopenia in Pregnancy: A French Nationwide Prospective Multicenter Observational Case-Control Study

C. Haioun, N. Costedoat-Chalumeau, J. Viallard, 2020 .

Eltrombopag in adult patients with immune thrombocytopenia in the real‐world in France, including off‐label use before 6 months of disease duration: The multicenter, prospective ELEXTRA study

M. Lapeyre-Mestre, A. Sommet, J. Viallard, 2021, American journal of hematology.

High dose romiplostim as a rescue therapy for adults with severe bleeding and refractory immune thrombocytopenia

L. Galicier, G. Moulis, M. Michel, 2020, American journal of hematology.

High-dose dexamethasone or oral prednisone for immune thrombocytopenia?

B. Godeau, 2016, The Lancet. Haematology.

A reservoir of rituximab-resistant splenic memory B cells contributes to relapses after B-cell depletion therapy

J. Weill, C. Reynaud, V. Meignin, 2019 .

Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study.

M. Dougados, C. Cazalets, P. Dieudé, 2023, The Lancet. Rheumatology.

Switching From Romiplostim to Eltrombopag or Vice Versa for Immune Thrombocytopenia: Efficacy and Safety in 46 Patients

F. Jardin, P. Bierling, C. Haioun, 2012 .

Efficacy of Biological-Targeted Treatments in Takayasu ArteritisCLINICAL PERSPECTIVE

E. Messas, Z. Amoura, J. Sibilia, 2015 .

Qualitative monitoring of SARS-CoV-2 mRNA vaccination in humans using droplet microfluidics

A. Meola, F. Rey, J. Baudry, 2023, JCI insight.

Letter to the Editor

M. Michel, A. Schaeffer, B. Godeau, 2004 .

Factors associated withPneumocystis carinii pneumonia inWegener's granulomatosisf

J. Piette, J. Mainardi, P. Rémy, 1995 .

Severe autoimmune type V hyperlipidemia preceding a systemic lupus erythematosus in a 15 year-old girl

M. Michel, B. Godeau, E. Foïs, 2007, Lupus.

The European Survey on Adult’s Evans Syndrome: Analysis of 54 Cases.

F. Rodeghiero, M. Michel, B. Godeau, 2005 .

[Update on immune thrombocytopenic purpura in adults].

B. Godeau, 2007, La Revue de medecine interne.

Characteristics of Sarcoidosis-Associated Immune Thrombocytopenia: a Consecutive Study of 20 Cases.

L. Chiche, N. Schleinitz, D. Valeyre, 2009 .

SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals.

A. Meola, F. Rey, J. Pawlotsky, 2023, Immunity.

Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study.

B. Bonnotte, J. Viallard, L. Galicier, 2023, Blood.

Clinical severity in adult warm autoimmune hemolytic anemia and its relationship to antibody specificity

P. Bierling, R. Djoudi, F. Pirenne, 2018, Haematologica.

Syndrome des antiphospholipides

B. Godeau, 2006 .

Treatment of chronic autoimmune thrombocytopenic purpura with monoclonal anti‐D

É. Oksenhendler, P. Bierling, A. Schaeffer, 1996, Transfusion.

No impact of PTPN22, PTPRJ and ACP1 genes polymorphisms on the risk of immune thrombocytopenia in French adult patients.

Y. Gruel, M. Michel, B. Godeau, 2016, Thrombosis research.

Association of Sarcoidosis and Immune Thrombocytopenia: Presentation and Outcome in a Series of 20 Patients

L. Chiche, D. Boutboul, N. Schleinitz, 2011, Medicine.

Safety and Efficacy Of Rituximab In adult’s Immune Thrombocytopenia (ITP) : Results After One-Year Of Follow-Up In 252 Patients From The Prospective French ITP-Ritux Registry

P. Bierling, A. Delmer, J. Viallard, 2013 .

Efficacy and safety of two rituximab biosimilars for treating immune thrombocytopenia: a reference-product matched study.

B. Bonnotte, J. Viallard, L. Galicier, 2023, Platelets.

Lack of relevance of the acetylator status on dapsone response in chronic autoimmune thrombocytopenic purpura

P. Bierling, B. Godeau, J. Duché, 1999, American journal of hematology.

High‐dose dexamethasone therapy for resistant autoimmune thrombocytopenic purpura

É. Oksenhendler, E. Deconinck, B. Wechsler, 1996, American journal of hematology.

Chronic refractory immune thrombocytopenia in adolescents and young adults

G. Moulis, B. Godeau, N. Aladjidi, 2023, British journal of haematology.

A Multicenter, Case-Control Study Evaluating the Characteristics and Outcome of ITP Patients Refractory to, Rituximab, Splenectomy and Both TPO Receptor Agonists

G. Salles, C. Haioun, I. Durieu, 2015 .

Clinical Epidemiology and First-Line Treatment in Immune Thrombocytopenia Adults. Results of the Carmen Prospective Cohort

M. Lapeyre-Mestre, G. Martin-Blondel, G. Moulis, 2015 .

No evidence of clinical efficacy of hydroxychloroquine in patients hospitalised for COVID-19 infection and requiring oxygen: results of a study using routinely collected data to emulate a target trial

N. Roche, L. Mouthon, N. Costedoat-Chalumeau, 2020 .

Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry.

E. Vignon, P. Ravaud, X. Mariette, 2010, Arthritis and rheumatism.

The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells.

J. Weill, C. Reynaud, C. Staib, 2008, Blood.

Acute kidney injury in sickle patients with painful crisis or acute chest syndrome and its relation to pulmonary hypertension.

L. Brochard, C. Brun-Buisson, Y. Lévy, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Clinical significance of antinuclear antibodies in primary immune thrombocytopenia

G. Moulis, B. Godeau, N. Aladjidi, 2023, British journal of haematology.

Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.

E. Neufeld, P. Bierling, J. Bussel, 2012, Blood.

The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases.

J. Piette, E. Andrès, P. Bierling, 2009, Blood.

Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease.

F. Roudot-thoraval, L. Brochard, C. Brun-Buisson, 2008, American journal of respiratory and critical care medicine.

[Treatment of systemic autoimmune and inflammatory diseases with rituximab].

L. Mouthon, J. Sibilia, E. Hachulla, 2009, Presse medicale.

Rituximab Is an Alternative to Splenectomy in Adults with Chronic Immune Thrombocytopenic Purpura: Results of a Multicenter Prospective Phase 2 Study.

R. Porcher, A. Vekhoff, P. Bierling, 2006 .